severe haematocytopenias were observed in patients undergoing high-dose chemotherapy.
在进行高剂量化疗的患者中观察到严重的血细胞减少。
idiopathic haematocytopenias often require extensive diagnostic testing to rule out malignancy.
特发性血细胞减少通常需要进行广泛的诊断检查以排除恶性肿瘤。
drug-induced haematocytopenias remain a significant concern in clinical pharmacology.
药物引起的血细胞减少仍然是临床药理学中的一个重要问题。
the patient presented with symptoms attributable to marked haematocytopenias.
患者出现了与显著血细胞减少相关的症状。
bone marrow biopsies are essential for diagnosing unexplained haematocytopenias.
骨髓活检对于诊断原因不明的血细胞减少至关重要。
refractory haematocytopenias may indicate an underlying myelodysplastic syndrome.
难治性血细胞减少可能提示存在潜在的骨髓增生异常综合征。
researchers linked the chemical exposure to the development of chronic haematocytopenias.
研究人员将化学物质暴露与慢性血细胞减少的发展联系起来。
management of haematocytopenias frequently involves transfusion support and growth factors.
血细胞减少的管理通常涉及输血支持和生长因子。
viral infections are sometimes associated with transient haematocytopenias in children.
病毒感染有时与儿童的暂时性血细胞减少有关。
immune-mediated haematocytopenias generally respond well to immunosuppressive therapies.
免疫介导的血细胞减少通常对免疫抑制治疗反应良好。
the guidelines provide a framework for evaluating peripheral haematocytopenias.
指南为评估外周血细胞减少提供了框架。
inherited haematocytopenias can result from various genetic mutations affecting hematopoiesis.
遗传性血细胞减少可能由影响造血的多种遗传突变引起。
severe haematocytopenias were observed in patients undergoing high-dose chemotherapy.
在进行高剂量化疗的患者中观察到严重的血细胞减少。
idiopathic haematocytopenias often require extensive diagnostic testing to rule out malignancy.
特发性血细胞减少通常需要进行广泛的诊断检查以排除恶性肿瘤。
drug-induced haematocytopenias remain a significant concern in clinical pharmacology.
药物引起的血细胞减少仍然是临床药理学中的一个重要问题。
the patient presented with symptoms attributable to marked haematocytopenias.
患者出现了与显著血细胞减少相关的症状。
bone marrow biopsies are essential for diagnosing unexplained haematocytopenias.
骨髓活检对于诊断原因不明的血细胞减少至关重要。
refractory haematocytopenias may indicate an underlying myelodysplastic syndrome.
难治性血细胞减少可能提示存在潜在的骨髓增生异常综合征。
researchers linked the chemical exposure to the development of chronic haematocytopenias.
研究人员将化学物质暴露与慢性血细胞减少的发展联系起来。
management of haematocytopenias frequently involves transfusion support and growth factors.
血细胞减少的管理通常涉及输血支持和生长因子。
viral infections are sometimes associated with transient haematocytopenias in children.
病毒感染有时与儿童的暂时性血细胞减少有关。
immune-mediated haematocytopenias generally respond well to immunosuppressive therapies.
免疫介导的血细胞减少通常对免疫抑制治疗反应良好。
the guidelines provide a framework for evaluating peripheral haematocytopenias.
指南为评估外周血细胞减少提供了框架。
inherited haematocytopenias can result from various genetic mutations affecting hematopoiesis.
遗传性血细胞减少可能由影响造血的多种遗传突变引起。
探索常用高频词汇